← Return to Codex Index

Tomorrow.bio advantage

Cryopreservation quality is decided in the field, in the hours after legal death, and by the institutions that have to keep working for decades afterwards. This topic exists to explain what Tomorrow.bio has built around that fact: a European response operation with whole-body field cryoprotection, standardized quality measurement for every patient, a Swiss long-term storage facility run by a separate foundation, engineering that starts from real cases, and research that keeps today's procedures and tomorrow's revival work clearly apart. It also covers the founders, the membership model and what happens step by step when a member needs us. The goal is to let you judge the organization on evidence rather than on claims.